Tenon Medical Inc. has announced that the U.S. Food and Drug Administration (FDA) has granted an expanded indication for the use of their Catamaran® SI Joint Fusion System. This approval allows the system to be used to augment immobilization and stabilization of the sacroiliac (SI) joint for patients undergoing sacropelvic fixation as part of a lumbar fusion. The company believes this regulatory milestone will open a substantial new market opportunity by addressing the need for robust SI joint stabilization in complex spinal fusion procedures. This expanded indication aims to enhance patient care for those suffering from SI joint disorders by providing a dependable and efficient method for authentic SI joint fusion.